Skip to main content
Premium Trial:

Request an Annual Quote

The Genetics Company, Discovery Partners to Screen Drug Candidates for Colon Cancer

NEW YORK, Sept. 24 – The Genetics Company and Discovery Partners have partnered to identify potential drug targets for colon cancer, the companies said on Monday.

Discovery Partners, of San Diego, will screen thousands of chemical compounds for their ability to inhibit a protein that The Genetics Company has in previous studies linked to colon cancer.

The agreement calls for The Genetics Company, of Zurich, Switzerland, to hold patent rights to any drug candidates that result from the research. In return, the company will pay Discovery Partners milestone payments and fees, including those for completed experiments and access to the substance libraries.

Further financial details were not disclosed.

The Genetics Company, which is privately held, uses its mouse and fruit fly model systems in functional genomics to help discover new drug targets. In addition to colon cancer, the company hopes to develop therapeutic compounds for endocrine disorders, inflammatory conditions, tissue regeneration, parasites, and other cancers.

In May, Discovery Partners completed its $1.7 million acquisition of Xenometrix , a Colorado-based developer of assays for screening drug candidates.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.